Clinical Trial Update: Micardis®. Observational Study in Patients With Essential Hypertension

View source ↗

Summary

This update reports the completion of an observational study of telmisartan (Micardis) in adults with essential hypertension; no new regulatory actions are desc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• Micardis (telmisartan)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Hypertension | Status: COMPLETED